EU Industry Benchmark
Pharma
Anonymized security posture data for the pharma sector across the EU. Based on 13679 monitored sites.
45.2
Avg. Score /100
D
Avg. Grade
13679
Sites Tracked
+2.0
vs. EU Average
Critical findings in this industry
7358 of 13679 without HTTPS redirect
7986 of 13679 with unencrypted email (no STARTTLS)
11205 of 13679 without DMARC protection (spoofable)
6937 of 13679 missing 3+ critical security headers
12328 of 13679 without DNSSEC (vulnerable to DNS spoofing)
13418 of 13679 without CAA records (unrestricted certificate issuance)
13636 of 13679 without MTA-STS (email downgrade attacks possible)
Grade Distribution
Security across Europe
Average security score by country — hover for details, click to explore.
/100 · sites
Score by Country
Hosting & Data Residency
52%
EU-headquartered provider
48%
Non-EU provider (CLOUD Act / Schrems II)
Server location via IP geolocation (MaxMind GeoLite2). Company HQ from ASN registry. A site may be physically hosted in the EU but use a US-headquartered provider subject to the CLOUD Act — per Schrems II (CJEU C-311/18), this requires SCCs with supplementary measures. · GDPR Art. 44–49
All data is anonymized. No individual sites are identified. Statistics updated weekly.